An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study. The results could potentially lead to new therapies ...
RELATED: 36-Year-Old Colon Cancer Patient Shares "Very Confusing" First Symptom ... the couple received the news that John had a brain tumor. John underwent brain surgery just five days later, with a ...
Diet Is Main Risk Factor for Colon Cancer in Younger Adults, New Study Suggests Aug. 14, 2024 — A new study has identified diet-derived molecules called metabolites as main drivers of young ...